Literature DB >> 33740220

Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways.

Sherihan Salaheldin Abdelhamid Ibrahim1, Kristiina M Huttunen2.   

Abstract

Cell signaling is considered a part of a network for communication that regulates basic cellular activities. The ability of cells to communicate correctly to the surrounding environment has an important role in development, tissue repair, and immunity as well as normal tissue homeostasis. Dysregulated activation and crosstalk between many intracellular signaling pathways are implicated in the pathogenesis of rheumatoid arthritis (RA), such as the Janus Kinase/signal transducers and activators of transcription (JAK/STAT), Toll-like receptor/nuclear factor kappa B (TLR/NF-κB), phosphatidylinositide-3Kinase/protein kinase B/mammalian target of rapamycin (PI-3K/AKT/mTOR), the stress activated protein kinase/mitogen-activated protein kinase (SAPK/MAPK), and spleen tyrosine kinase (SYK) pathways. Other interrelated pathways that can be targeted to halt the inflammatory status in the disease are purinergic 2X7 receptor (P2X7R)/nucleotide binding oligomerization domain-like receptor family pyrin domain containing 3 or inflammasome (NLRP-3)/NF-κB and Notch pathways. In this review, we will show the orchestrated modulation in the pathogenesis of RA via the crossregulation between dysregulated signaling pathways which can mediate a sustained loop of activation for these signaling pathways as well as aggrevate the inflammatory condition. Also, this review will highlight many targets that can be useful in the development of more effective therapeutic options.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  JAK/STAT; P2X7R/NLRP-3; PI-3K/AKT/mTOR; SAPK/MAPK; SYK; TLR/NF-κB

Mesh:

Substances:

Year:  2021        PMID: 33740220     DOI: 10.1007/s10787-021-00800-3

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  34 in total

1.  The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.

Authors:  David Torres; Sandrine Delbauve; Ezra Aksoy; Salma Taboubi; Abderrahman Hachani; Maria A Whitehead; Wayne P Pearce; Inma M Berenjeno; Gemma Nock; Alain Filloux; Rudi Beyaert; Veronique Flamand; Bart Vanhaesebroeck
Journal:  Nat Immunol       Date:  2012-09-30       Impact factor: 25.606

2.  Nuclear factor-kappa B regulates pain and COMT expression in a rodent model of inflammation.

Authors:  Jane E Hartung; Olivia Eskew; Terrence Wong; Inna E Tchivileva; Folabomi A Oladosu; Sandra C O'Buckley; Andrea G Nackley
Journal:  Brain Behav Immun       Date:  2015-07-15       Impact factor: 7.217

Review 3.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Authors:  Peter C Heinrich; Iris Behrmann; Serge Haan; Heike M Hermanns; Gerhard Müller-Newen; Fred Schaper
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

4.  Involvement of P2X7 receptor signaling on regulating the differentiation of Th17 cells and type II collagen-induced arthritis in mice.

Authors:  Zhi-Dan Fan; Ya-Yuan Zhang; Yi-Hong Guo; Na Huang; Hui-Hui Ma; Hui Huang; Hai-Guo Yu
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

Review 5.  Targeting Syk in Autoimmune Rheumatic Diseases.

Authors:  Guo-Min Deng; Vasileios C Kyttaris; George C Tsokos
Journal:  Front Immunol       Date:  2016-03-07       Impact factor: 7.561

Review 6.  A critique on nuclear factor-kappa B and signal transducer and activator of transcription 3: The key transcription factors in periodontal pathogenesis.

Authors:  Ranjith Ambili; Presanthila Janam
Journal:  J Indian Soc Periodontol       Date:  2017 Sep-Oct

Review 7.  The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.

Authors:  Geoffrey Burnstock; Gillian E Knight
Journal:  Purinergic Signal       Date:  2017-11-21       Impact factor: 3.765

Review 8.  Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis.

Authors:  Qinghua Fang; Chun Zhou; Kutty Selva Nandakumar
Journal:  Mediators Inflamm       Date:  2020-03-17       Impact factor: 4.711

9.  Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis.

Authors:  Christianna Choulaki; Garyfallia Papadaki; Argyro Repa; Eleni Kampouraki; Konstantinos Kambas; Konstantinos Ritis; George Bertsias; Dimitrios T Boumpas; Prodromos Sidiropoulos
Journal:  Arthritis Res Ther       Date:  2015-09-19       Impact factor: 5.156

Review 10.  Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments.

Authors:  Laura Duffy; Steven C O'Reilly
Journal:  Immunotargets Ther       Date:  2016-08-22
View more
  2 in total

1.  Targeting inflammation and redox perturbations by lisinopril mitigates Freund's adjuvant-induced arthritis in rats: role of JAK-2/STAT-3/RANKL axis, MMPs, and VEGF.

Authors:  Hany H Arab; Sarah A Abd El-Aal; Ahmed M Ashour; Azza A K El-Sheikh; Hana J Al Khabbaz; El-Shaimaa A Arafa; Ayman M Mahmoud; Ahmed M Kabel
Journal:  Inflammopharmacology       Date:  2022-06-28       Impact factor: 5.093

2.  The Immune Profile of Major Dysmood Disorder: Proof of Concept and Mechanism Using the Precision Nomothetic Psychiatry Approach.

Authors:  Michael Maes; Muanpetch Rachayon; Ketsupar Jirakran; Pimpayao Sodsai; Siriwan Klinchanhom; Piotr Gałecki; Atapol Sughondhabirom; Agnieszka Basta-Kaim
Journal:  Cells       Date:  2022-03-31       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.